CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 15,000
+260 (1.76%)
At close: Aug 14, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 193.58 billion as of August 14, 2026. Its market cap has decreased by -46.15% in one year.
Market Cap
193.58B
Enterprise Value
156.27B
Revenue
2.15B
Ranking
n/a
PE Ratio
24.98
Stock Price
15,000.00
ChartMarket Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 193.58B, a decrease of -26.41%. That is a compound annual growth rate of -15.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 193.58B | -36.08% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 300.74B |
| NOVAREX | 259.41B |
| Cosmax Nbt | 201.23B |
| DAE HWA Pharmaceutical | 191.28B |
| Vivozon Pharmaceutical | 172.67B |
| GC WellBeing | 166.27B |
| Ahn-Gook Pharmaceutical | 142.29B |
| Kyung Dong Pharmaceutical | 138.48B |